NewsStocks Acadia Pharmaceuticals Stock Sinks After Schizophrenia Drug Study Falls Short by admin 12/03/2024 12/03/2024 Key Takeaways Acadia Pharmaceuticals’ drug missed endpoints for treating schizophrenia patients, news that sent Acadia … 0 FacebookTwitterPinterestEmail
